Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))

Ritu Ojha; Kunal Nepali; Chun Han Chen; Kuo Hsiang Chuang; Tung Yun Wu; Tony Eight Lin; Kai Cheng Hsu; Min Wu Chao; Mei Jung Lai; Mei Hsiang Lin; Han Li Huang; Chao Di Chang; Shiow Lin Pan; Mei Chuan Chen; Jing Ping Liou

doi:10.1016/j.ejmech.2020.112404

Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))

Ritu Ojha, Kunal Nepali, Chun Han Chen, Kuo Hsiang Chuang, Tung Yun Wu, Tony Eight Lin, Kai Cheng Hsu, Min Wu Chao, Mei Jung Lai, Mei Hsiang Lin, Han Li Huang, Chao Di Chang, Shiow Lin Pan, Mei Chuan Chen, Jing Ping Liou

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

1 引文斯高帕斯（Scopus）

摘要

The authors regret that the information of the second corresponding author (M.-C. Chen) in the affiliation was misplaced. The correct version should be: Mei-Chuan Chena,b,h ∗∗ b Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. The authors would like to apologise for any inconvenience caused.

原文	英語
文章編號	112404
期刊	European Journal of Medicinal Chemistry
卷	201
DOIs	https://doi.org/10.1016/j.ejmech.2020.112404
出版狀態	已發佈 - 9月 1 2020

ASJC Scopus subject areas

藥理
藥物發現
有機化學

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1016/j.ejmech.2020.112404

其它文件與鏈接

Link to publication in Scopus

指紋

深入研究「Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))」主題。共同形成了獨特的指紋。

引用此

Ojha, R., Nepali, K., Chen, C. H., Chuang, K. H., Wu, T. Y., Lin, T. E., Hsu, K. C., Chao, M. W., Lai, M. J., Lin, M. H., Huang, H. L., Chang, C. D., Pan, S. L., Chen, M. C., & Liou, J. P. (2020). Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086)). European Journal of Medicinal Chemistry, 201, 文章 112404. https://doi.org/10.1016/j.ejmech.2020.112404

Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086)). / Ojha, Ritu; Nepali, Kunal ; Chen, Chun Han 等.
於: European Journal of Medicinal Chemistry, 卷 201, 112404, 01.09.2020.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Ojha, R, Nepali, K , Chen, CH , Chuang, KH, Wu, TY, Lin, TE, Hsu, KC, Chao, MW, Lai, MJ , Lin, MH, Huang, HL, Chang, CD, Pan, SL , Chen, MC & Liou, JP 2020, 'Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))', European Journal of Medicinal Chemistry, 卷 201, 112404. https://doi.org/10.1016/j.ejmech.2020.112404

Ojha R, Nepali K , Chen CH , Chuang KH, Wu TY, Lin TE 等. Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086)). European Journal of Medicinal Chemistry. 2020 9月 1;201:112404. doi: 10.1016/j.ejmech.2020.112404

Ojha, Ritu ; Nepali, Kunal ; Chen, Chun Han 等. / Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086)). 於: European Journal of Medicinal Chemistry. 2020 ; 卷 201.

@article{8bd15ecfdb704d7eb50622188bd296a8,

title = "Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))",

abstract = "The authors regret that the information of the second corresponding author (M.-C. Chen) in the affiliation was misplaced. The correct version should be: Mei-Chuan Chena,b,h ∗∗ b Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. The authors would like to apologise for any inconvenience caused.",

author = "Ritu Ojha and Kunal Nepali and Chen, {Chun Han} and Chuang, {Kuo Hsiang} and Wu, {Tung Yun} and Lin, {Tony Eight} and Hsu, {Kai Cheng} and Chao, {Min Wu} and Lai, {Mei Jung} and Lin, {Mei Hsiang} and Huang, {Han Li} and Chang, {Chao Di} and Pan, {Shiow Lin} and Chen, {Mei Chuan} and Liou, {Jing Ping}",

note = "Publisher Copyright: {\textcopyright} 2020",

year = "2020",

month = sep,

day = "1",

doi = "10.1016/j.ejmech.2020.112404",

language = "English",

volume = "201",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))

AU - Ojha, Ritu

AU - Nepali, Kunal

AU - Chen, Chun Han

AU - Chuang, Kuo Hsiang

AU - Wu, Tung Yun

AU - Lin, Tony Eight

AU - Hsu, Kai Cheng

AU - Chao, Min Wu

AU - Lai, Mei Jung

AU - Lin, Mei Hsiang

AU - Huang, Han Li

AU - Chang, Chao Di

AU - Pan, Shiow Lin

AU - Chen, Mei Chuan

AU - Liou, Jing Ping

PY - 2020/9/1

Y1 - 2020/9/1

N2 - The authors regret that the information of the second corresponding author (M.-C. Chen) in the affiliation was misplaced. The correct version should be: Mei-Chuan Chena,b,h ∗∗ b Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the information of the second corresponding author (M.-C. Chen) in the affiliation was misplaced. The correct version should be: Mei-Chuan Chena,b,h ∗∗ b Ph.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85086120602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086120602&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2020.112404

DO - 10.1016/j.ejmech.2020.112404

M3 - Comment/debate

C2 - 32526554

AN - SCOPUS:85086120602

SN - 0223-5234

VL - 201

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

M1 - 112404

ER -